This will be a two-day meeting for clinical pharmacologists, scientists and pediatricians to discuss overcoming the scientific challenges using tools such as models & simulations and PK & PD studies to optimise the development of new pediatric medicines.It is well known that recent regulatory changes in the USA and Europe have made it mandatory to further development of medicines for children. Many previous discussions have taken place on the impact these regulatory changes have had or the difficult topics of locating willing pediatric populations and informed consent......................& more.
No comments:
Post a Comment